MedTrace Logo

Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies

NCT03751644 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2021-04-30

No results posted yet for this study

Summary

Systemic autoimmune myopathies are a heterogeneous group of rheumatic diseases with progressive skeletal muscle weakness. The relevance of the peripherical neuromuscular electrical stimulation has never applied in the patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, investigator-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of an acute peripherical neuromuscular electrical stimulation session in patients with systemic autoimmune myopathies.

Conditions

  • Electrical Remodeling
  • Rheumatic Diseases
  • Myopathy

Interventions

OTHER

Electrical stimulation

Patients with systemic autoimmune myopathies will receive peripheral electrical stimulation in thigh muscles

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Samuel K Shinjo · Universidade de Sao Paulo - Rheumatology Division

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2021-04-29
Completion
2021-04-29

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03751644 on ClinicalTrials.gov